Biological Drug API Manufacturing Services Market Report 2021-2031

Biological Drug API Manufacturing Services Market Report 2021-2031

Biological Drug API Manufacturing Services Set to Witness Significant Growth Over Next 10 Years

The opportunity to become a market leader in the rapidly growing biosimilar industry has spurred many companies to invest in biosimilar development, either directly or through a partnership with a more experienced CMO. Currently, in 2020, there are over 55 approved biosimilars in the EU and the market for these products is expected to grow rapidly in the coming 10 years. Demand for lower-cost biological therapies in developed and emerging markets, as well as patent expires for blockbuster biologics, will drive investment in biosimilar development. CMOs that can offer expertise and biomanufacturing capacity will benefit from contracts with biosimilar developers, such as small molecule generic drug manufacturers, as well as emerging biosimilar manufacturers looking to launch their follow-on biologics in developed markets.

U.S. Holds the Maximum Market Share in Global Biological Drug API Manufacturing Services Market

The US is the global leader of the biological drug API manufacturing service market and this is no surprise as it also has the highest level of demand worldwide for pharmaceuticals, including outsourced API manufacturing. Per person, the US spends around one thousand dollars a year on pharmaceuticals, higher than any other country in the world. Additionally, pharmaceuticals cost more in the US, with some drugs being twice the price they are in the UK and Canada. This is because the US government does not regulate its pharma prices. Furthermore, the opaque US health system makes it hard to draw drug-by-drug comparisons with prices abroad. The majority of the leading biotech CMOs have facilities in the United States, which provide APIs domestically. In 2020, US market accounted for US$ xx million, or over 90%, of the North American biological drug API manufacturing services revenues. Emerging markets are no longer as cheap as they used to be and additionally, emerging markets do not always meet quality standards. This deficiency in standards and rise in costs because of the demands for compliance to standards has increased the demand in the US market. Local manufacturers can also provide products more conveniently, as there are less communication or timing issues.

Discover how to stay ahead

Our 350+ page report provides 350+ tables and charts/graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Biological Drug API Manufacturing Services Market. See how to exploit the opportunities.

Forecasts to 2031 and other analyses reveal the commercial prospects

  • In addition to revenue forecasting to 2031, our new study provides you with recent results, growth rates, and market shares.
  • You find original analyses, with business outlooks and developments.
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints, and challenges), SWOT Analysis, product profiles and commercial developments.
Discover sales predictions for the world market and sub-markets.

By Manufacturing Type
  • Outsourced
  • In-house
By Expression Platform
  • Mammalian Cell Cultures
  • Microbial Fermentations
  • Others
By Application
  • Vaccines
  • MABs
  • Insulin Analogues
  • Interferon Therapies
  • Human Growth Hormones
  • Other Therapeutic Areas
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 22 leading national markets:

By Region
  • North America
U.S.

Canada
  • Europe
Germany

France

UK

Italy

Spain

Russia

Switzerland

Netherlands

Rest of Europe
  • Asia Pacific
China

Japan

India

Australia

South Korea

Singapore

Rest of Asia Pacific
  • Latin America
Brazil

Mexico

Colombia

Argentina

Rest of Latin America
  • Middle East & Africa
GCC

South Africa

Rest of Middle East & Africa

Leading companies and the potential for market growth

Overall world revenue for Biological Drug API Manufacturing Services Market will surpass $xx million in 2021, our work calculates. We predict strong revenue growth through to 2031. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How the Biological Drug API Manufacturing Services Market report helps you

In summary, our 350+ page report provides you with the following knowledge:
  • Revenue forecasts to 2031 for Biological Drug API Manufacturing Services Market, with forecasts for Manufacturing Type, Expression Platform, and Application, each forecasted at a global and regional leveldiscover the industry’s prospects, finding the most lucrative places for investments and revenues
  • Revenue forecasts to 2031 for 5 regional and 22 key national marketsSee forecasts for the Biological Drug API Manufacturing Services market in North America, Europe, Asia Pacific, and Rest of the World. Also forecasted is the market in the US, Canada, Brazil, Mexico, Germany, France, UK, Italy, Spain, Russia, Switzerland, Netherlands, China, India, Japan, Australia, South Korea, Singapore, among other prominent economies.
  • Prospects for established firms and those seeking to enter the marketincluding company profiles for 10 of the major companies involved in the Biological Drug API Manufacturing Services Market. Some of the company’s profiled in this report include Bristol-Myers Squibb Co., Samsung Biologics, AbbVie, GSK Biopharmaceuticals, Lonza Group Ltd., NEKTAR THERAPEUTICS, Boehringer, Patheon N.V., Cytovance Biologics, and Fujifilm Diosynth Biotechnologies.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Please Note: Prior to initiating fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.

The publisher is using a password system to access all reports. Single user (non-printable) and departmental licenses expires after 12 month period. In the case of departmental site license purchases, the publisher requires all email addresses for the licensed users prior to fulfillment.


1. Report Overview
1.1 Introduction to Biological Drug API Manufacturing Services Market
1.2 Why You Should Read This Report
1.3 What This Report Delivers
1.4 Key Questions Answered By This Analytical Report Include:
1.5 Who is This Report For?
1.6 Methodology
1.6.1 COVID-19 Impact: Recovery Scenarios
1.6.2 Market Evaluation & Forecasting Methodology
1.7 Frequently Asked Questions (FAQs)
1.8 Associated Visiongain Reports
1.9 About Visiongain
2 Executive Summary
3 Industry Insights
3.1 Drivers
3.1.1 Biological Patent Expirations to Fuel Market Growth
3.1.2 Outsourcing as a Driver for Market Growth
3.1.3 Growing Investments in Orphan Drugs
3.1.4 Emerging Economies to Offer Lucrative Growth Opportunities
3.1.5 Single Use Technology will Become Essential Over the Next Decade
3.2 Restraints
3.2.1 Manufacturing APIs for Biologics to Restrain Market Growth
3.2.2 Pricing Pressure to Impede Market Growth Through 2031
3.2.3 Regulatory Scenarios to Restrain Market Growth
3.2.4 Excessive Production is Projected to Impede Market Growth
3.2.5 API Production is a Challenging Task
3.3 SWOT Analysis
3.3.1 Strengths
3.3.2 Weaknesses
3.3.3 Opportunities
3.3.4 Threats
3.4 Industry analysis – PEST Analysis
3.4.1 Political
3.4.2 Economical
3.4.3 Social
3.4.4 Technological
4 Biological Drug API Manufacturing Services Market by Manufacturing Type
4.1 Outsourced Segment Market Forecast, 2021-2031
4.1.1 Recovery Scenarios (V, U, W, L)
4.2 In-house Segment Market Forecast, 2021-2031
4.2.1 Recovery Scenarios (V, U, W, L)
5 Biological Drug API Manufacturing Services Market by Expression Platform
5.1 Mammalian Cell Cultures Segment Market Forecast, 2021-2031
5.1.1 Introduction
5.1.2 Recovery Scenarios (V, U, W, L)
5.2 Microbial Fermentations Segment Market Forecast, 2021-2031
5.2.1 Introduction
5.2.2 Recovery Scenarios (V, U, W, L)
5.3 Others Segment Market Forecast, 2021-2031
5.3.1 Introduction
5.3.2 Recovery Scenarios (V, U, W, L)
6 Biological Drug API Manufacturing Services Market by Application
6.1 Vaccines Segment Market Forecast, 2021-2031
6.1.1 Introduction
6.1.2 Recovery Scenarios (V, U, W, L)
6.2 MABs Segment Market Forecast, 2021-2031
6.2.1 Introduction
6.2.2 Recovery Scenarios (V, U, W, L)
6.3 Insulin Analogues Segment Market Forecast, 2021-2031
6.3.1 Introduction
6.3.2 Recovery Scenarios (V, U, W, L)
6.4 Interferon Therapies Segment Market Forecast, 2021-2031
6.4.1 Introduction
6.4.2 Recovery Scenarios (V, U, W, L)
6.5 Human Growth Hormones Segment Market Forecast, 2021-2031
6.5.1 Introduction
6.5.2 Recovery Scenarios (V, U, W, L)
6.6 Other Therapeutic Areas Segment Market Forecast, 2021-2031
6.6.1 Recovery Scenarios (V, U, W, L)
7 Regional and Leading National Biological Drug API Manufacturing Services Market Forecasts 2021-2031
7.1 Global Biological Drug API Manufacturing Services Market by Region Forecast 2021-2031
7.2 Recovery Scenarios (V, U, W, L)
8 North America Biological Drug API Manufacturing Services Market, 2021-2031
8.1 North America Biological Drug API Manufacturing Services Market by Country Forecast 2021-2031
8.2 U.S. Biological Drug API Manufacturing Services Market Forecast, 2021-2031
8.2.1 Largest Biological Drug API Manufacturing Market Across the Globe
8.2.2 Biologics Approved by FDA in 2019
8.2.3 Recovery Scenarios (V, U, W, L): U.S. Biological Drug API Manufacturing Services Market Forecast, 2021-2031
8.3 Canada Biological Drug API Manufacturing Services Market Forecast, 2021-2031
8.3.1 Growing Entrance of Biosimilars in Canadian Market
8.3.2 Recovery Scenarios (V, U, W, L): Canada Biological Drug API Manufacturing Services Market Forecast, 2021-2031
9 Europe Biological Drug API Manufacturing Services Market, 2021-2031
9.1 Europe Biological Drug API Manufacturing Services Market by Country Forecast 2021-2031
9.2 Germany Biological Drug API Manufacturing Services Market Forecast, 2021-2031
9.2.1 Germany Has Well Established Biomanufacturing Industry
9.2.2 Recovery Scenarios (V, U, W, L): Germany Biological Drug API Manufacturing Services Market Forecast, 2021-2031
9.3 France Biological Drug API Manufacturing Services Market Forecast, 2021-2031
9.3.1 France is one of the Leading Pharmaceutical Manufacturing Industry in Europe
9.3.2 Recovery Scenarios (V, U, W, L): France Biological Drug API Manufacturing Services Market Forecast, 2021-2031
9.4 UK Biological Drug API Manufacturing Services Market Forecast, 2021-2031
9.4.1 Strong Biopharma Industry Across UK to Fuel Market Growth
9.4.2 Recovery Scenarios (V, U, W, L): UK Biological Drug API Manufacturing Services Market Forecast, 2021-2031
9.5 Italy Biological Drug API Manufacturing Services Market Forecast, 2021-2031
9.5.1 Recovery Scenarios (V, U, W, L): Italy Biological Drug API Manufacturing Services Market Forecast, 2021-2031
9.6 Spain Biological Drug API Manufacturing Services Market Forecast, 2021-2031
9.6.1 Recovery Scenarios (V, U, W, L): Spain Biological Drug API Manufacturing Services Market Forecast, 2021-2031
9.7 Russia Biological Drug API Manufacturing Services Market Forecast, 2021-2031
9.7.1 Recovery Scenarios (V, U, W, L): Russia Biological Drug API Manufacturing Services Market Forecast, 2021-2031
9.8 Switzerland Biological Drug API Manufacturing Services Market Forecast, 2021-2031
9.8.1 Recovery Scenarios (V, U, W, L): Switzerland Biological Drug API Manufacturing Services Market Forecast, 2021-2031
9.9 Netherlands Biological Drug API Manufacturing Services Market Forecast, 2021-2031
9.9.1 Recovery Scenarios (V, U, W, L): Netherlands Biological Drug API Manufacturing Services Market Forecast, 2021-2031
9.10 Rest of Europe Biological Drug API Manufacturing Services Market Forecast, 2021-2031
9.10.1 Recovery Scenarios (V, U, W, L): Rest of Europe Biological Drug API Manufacturing Services Market Forecast, 2021-2031
10 Asia Pacific Biological Drug API Manufacturing Services Market, 2021-2031
10.1 Asia Pacific Biological Drug API Manufacturing Services Market by Country Forecast 2021-2031
10.2 Japan Biological Drug API Manufacturing Services Market Forecast, 2021-2031
10.2.1 Increased Competition from U.S. in Generics and Patented Environment, and China in Terms of API
10.2.2 Japanese Government to Cut Healthcare Costs to Boost Generics and Biosimilar Sectors
10.2.3 Recovery Scenarios (V, U, W, L): Japan Biological Drug API Manufacturing Services Market Forecast, 2021-2031
10.3 India Biological Drug API Manufacturing Services Market Forecast, 2021-2031
10.3.1 India Biological Drug API Manufacturing Services Market to Witness Fastest Growth Rate from 2021 to 2031
10.3.2 Infusion of US$ 1.2 billion in Pharmaceutical Industry by Indian Government to Boost Domestic API Capabilities Amid COVID-19
10.3.3 Growing Public Healthcare Sector to Fuel Market Growth
10.3.4 Recovery Scenarios (V, U, W, L): India Biological Drug API Manufacturing Services Market Forecast, 2021-2031
10.4 China Biological Drug API Manufacturing Services Market Forecast, 2021-2031
10.4.1 China is Most Popular Outsourcing Destination
10.4.2 Challenges Amid COVID-19
10.4.3 Recovery Scenarios (V, U, W, L): China Biological Drug API Manufacturing Services Market Forecast, 2021-2031
10.5 Australia Biological Drug API Manufacturing Services Market Forecast, 2021-2031
10.5.1 Availability of Biologics & Biosimilar Medicines is Anticipated to Have a Positive Impact on Australian Healthcare System
10.5.2 Recovery Scenarios (V, U, W, L): Australia Biological Drug API Manufacturing Services Market Forecast, 2021-2031
10.6 South Korea Biological Drug API Manufacturing Services Market Forecast, 2021-2031
10.6.1 Samsung Biologics Expansion Plan to Offer Lucrative Growth Opportunities for South Korean Market
10.6.2 Recovery Scenarios (V, U, W, L): South Korea Biological Drug API Manufacturing Services Market Forecast, 2021-2031
10.7 Singapore Biological Drug API Manufacturing Services Market Forecast, 2021-2031
10.7.1 Evolving Pharmaceutical Industry
10.7.2 Singapore Has Well Developed & Established Pharma Market
10.7.3 Recovery Scenarios (V, U, W, L): Singapore Biological Drug API Manufacturing Services Market Forecast, 2021-2031
10.8 Rest of Asia Pacific Biological Drug API Manufacturing Services Market Forecast, 2021-2031
10.8.1 Recovery Scenarios (V, U, W, L): Rest of Asia Pacific Biological Drug API Manufacturing Services Market Forecast, 2021-2031
11 Latin America Biological Drug API Manufacturing Services Market, 2021-2031
11.1 Latin America Biological Drug API Manufacturing Services Market by Country Forecast 2021-2031
11.2 Brazil Biological Drug API Manufacturing Services Market Forecast, 2021-2031
11.2.1 Recovery Scenarios (V, U, W, L): Brazil Biological Drug API Manufacturing Services Market Forecast, 2021-2031
11.3 Argentina Biological Drug API Manufacturing Services Market Forecast, 2021-2031
11.3.1 Recovery Scenarios (V, U, W, L): Argentina Biological Drug API Manufacturing Services Market Forecast, 2021-2031
11.4 Mexico Biological Drug API Manufacturing Services Market Forecast, 2021-2031
11.4.1 Introduction
11.4.2 Recovery Scenarios (V, U, W, L): Mexico Biological Drug API Manufacturing Services Market Forecast, 2021-2031
11.5 Colombia Biological Drug API Manufacturing Services Market Forecast, 2021-2031
11.5.1 Recovery Scenarios (V, U, W, L): Colombia Biological Drug API Manufacturing Services Market Forecast, 2021-2031
11.6 Rest of Latin America Biological Drug API Manufacturing Services Market Forecast, 2021-2031
11.6.1 Recovery Scenarios (V, U, W, L): Rest of Latin America Biological Drug API Manufacturing Services Market Forecast, 2021-2031
12 Middle East and Africa Biological Drug API Manufacturing Services Market, 2021-2031
12.1 Middle East and Africa Biological Drug API Manufacturing Services Market by Country Forecast 2021-2031
12.2 GCC Biological Drug API Manufacturing Services Market Forecast, 2021-2031
12.2.1 Recovery Scenarios (V, U, W, L): GCC Biological Drug API Manufacturing Services Market Forecast, 2021-2031
12.3 South Africa Biological Drug API Manufacturing Services Market Forecast, 2021-2031
12.3.1 Recovery Scenarios (V, U, W, L): South Africa Biological Drug API Manufacturing Services Market Forecast, 2021-2031
12.4 Rest of Middle East and Africa Biological Drug API Manufacturing Services Market Forecast, 2021-2031
12.4.1 Recovery Scenarios (V, U, W, L): Rest of Middle East and Africa Biological Drug API Manufacturing Services Market Forecast, 2021-2031
13 Company Profiles
13.1 Bristol-Myers Squibb Co.
13.1.1 Company Snapshot
13.1.2 Company Overview
13.1.3 Financial Analysis, 2015-2019
13.1.4 Product Benchmarking
13.1.5 Recent Developments, 2018-2020
13.2 Samsung Biologics Co., Ltd.
13.2.1 Company Snapshot
13.2.2 Company Overview
13.2.3 Financial Analysis, 2015 to 2019
13.2.4 Product Benchmarking
13.2.5 Recent Developments, 2019 to 2020
13.3 Abbvie Inc.
13.3.1 Company Snapshot
13.3.2 Company Overview
13.3.3 Financial Analysis, 2015 to 2019
13.3.4 Product Benchmarking
13.3.5 Recent Developments, 2018 to 2020
13.4 GlaxoSmithKline Plc
13.4.1 Company Snapshot
13.4.2 Company Overview
13.4.3 Financial Analysis, 2015 to 2019
13.4.4 Product Benchmarking
13.4.5 Recent Developments, 2018 to 2020
13.5 Lonza Group
13.5.1 Company Snapshot
13.5.2 Company Overview
13.5.3 Financial Analysis, 2015 to 2019
13.6 Teva Pharmaceutical Industries Ltd.
13.6.1 Company Snapshot
13.6.2 Company Overview
13.6.3 Financial Analysis, 2015 to 2019
13.7 Piramal Enterprises Ltd
13.7.1 Company Snapshot
13.7.2 Company Overview
13.7.3 Financial Analysis, 2015 to 2019
13.8 Boehringer Ingelheim International GmbH
13.8.1 Company Snapshot
13.8.2 Company Overview
13.8.3 Financial Analysis, 2015 to 2019
13.8.4 Product Benchmarking
13.8.5 Recent Developments, 2018 to 2020
13.9 Catalent Inc.
13.9.1 Company Snapshot
13.9.2 Company Overview
13.9.3 Financial Analysis, 2015 to 2019
13.10 Nektar Therapeutics
13.10.1 Company Snapshot
13.10.2 Company Overview
13.10.3 Financial Analysis, 2015 to 2019
13.10.4 Product Benchmarking
13.10.5 Recent Developments, 2018 to 2020
13.11 UCB SA
13.11.1 Company Snapshot
13.11.2 Company Overview
13.11.3 Financial Analysis, 2015 to 2019
13.11.4 Product Benchmarking
13.11.5 Recent Developments, 2018 to 2020
13.12 Biogen Inc.
13.12.1 Company Snapshot
13.12.2 Company Overview
13.12.3 Financial Analysis, 2015 to 2019
13.12.4 Product Benchmarking
13.12.5 Recent Developments, 2018 to 2020
13.13 Biocon
13.13.1 Company Snapshot
13.13.2 Company Overview
13.13.3 Financial Analysis, 2015 to 2019
13.13.4 Product Benchmarking
13.13.5 Recent Developments, 2018 to 2020
13.14 Regeneron Pharmaceuticals, Inc.
13.14.1 Company Snapshot
13.14.2 Company Overview
13.14.3 Financial Analysis, 2015 to 2019
13.14.4 Product Benchmarking
13.14.5 Recent Developments, 2018 to 2020
13.15 Sandoz
13.15.1 Company Snapshot
13.15.2 Company Overview
13.15.3 Product Benchmarking
13.15.4 Recent Developments, 2018 to 2020
13.16 Fujifilm Diosynth Biotechnologies
13.16.1 Company Snapshot
13.16.2 Company Overview
13.16.3 Product Benchmarking
13.16.4 Recent Developments, 2018 to 2020
14 Conclusion
List of Tables
Table 1 Global Biological Drug API Manufacturing Services Market Snapshot, 2021 & 2031 (US$ million, CAGR %)
Table 2 Global Biological Drug API Manufacturing Services Market Forecast by Manufacturing Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 3 Global Biological Drug API Manufacturing Services Market Forecast for Outsourced, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 4 Global Biological Drug API Manufacturing Services Market Forecast for Outsourced, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 5 Global Biological Drug API Manufacturing Services Market Forecast for Outsourced, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 6 Global Biological Drug API Manufacturing Services Market Forecast for Outsourced, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 7 Global Biological Drug API Manufacturing Services Market Forecast for Outsourced, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 8 Global Biological Drug API Manufacturing Services Market Forecast for Inhouse, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 9 Global Biological Drug API Manufacturing Services Market Forecast for Inhouse, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 10 Global Biological Drug API Manufacturing Services Market Forecast for Inhouse, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 11 Global Biological Drug API Manufacturing Services Market Forecast for Inhouse, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 12 Global Biological Drug API Manufacturing Services Market Forecast for Inhouse, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 13 Global Biological Drug API Manufacturing Services Market Forecast by Expression Platform, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 14 Global Biological Drug API Manufacturing Services Market Forecast for Mammalian Cell Culture, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 15 Global Biological Drug API Manufacturing Services Market Forecast for Mammalian Cell Culture, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 16 Global Biological Drug API Manufacturing Services Market Forecast for Mammalian Cell Culture, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 17 Global Biological Drug API Manufacturing Services Market Forecast for Mammalian Cell Culture, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 18 Global Biological Drug API Manufacturing Services Market Forecast for Mammalian Cell Culture, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 19 Global Biological Drug API Manufacturing Services Market Forecast for Microbial Fermentations, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 20 Global Biological Drug API Manufacturing Services Market Forecast for Microbial Fermentations, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 21 Global Biological Drug API Manufacturing Services Market Forecast for Microbial Fermentations, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 22 Global Biological Drug API Manufacturing Services Market Forecast for Microbial Fermentations, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 23 Global Biological Drug API Manufacturing Services Market Forecast for Microbial Fermentations, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 24 Global Biological Drug API Manufacturing Services Market Forecast for Other Expression Systems, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 25 Global Biological Drug API Manufacturing Services Market Forecast for Other Expression Systems, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 26 Global Biological Drug API Manufacturing Services Market Forecast for Other Expression Systems, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 27 Global Biological Drug API Manufacturing Services Market Forecast for Other Expression Systems, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 28 Global Biological Drug API Manufacturing Services Market Forecast for Other Expression Systems, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 29 Global Biological Drug API Manufacturing Services Market Forecast by Application, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 30 Global Biological Drug API Manufacturing Services Market Forecast for Vaccines, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 31 Global Biological Drug API Manufacturing Services Market Forecast for Vaccines, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 32 Global Biological Drug API Manufacturing Services Market Forecast for Vaccines, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 33 Global Biological Drug API Manufacturing Services Market Forecast for Vaccines, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 34 Global Biological Drug API Manufacturing Services Market Forecast for Vaccines, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
Table 35 Global Biological Drug API Manufacturing Services Market Forecast for mABs, 2021-2031 (US$ Mn, AGR%, CAGR%)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook